SCHEMBL20150364

SCHEMBL20150364

Cc1cc(-c2ccc3c(c2)c2ccccc2n3-c2cc(C#N)ccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.35
SYK P43405 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2C19 P33261 2/20 0.33
KMT2A Q03164 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
CYP2D6 P10635 2/20 0.33
TSHR P16473 2/20 0.33
MAT2A P31153 1/20 0.33
MAPK1 P28482 1/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GRM5 P41594 1/20 0.32
ABCG2 Q9UNQ0 6/20 0.32
RXRA P19793 1/20 0.32
RXRG P48443 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156276 0.94 PTGER4 (0.34) PTGER4CYP1A2CYP3A4MEN1ALDH1A1
SCHEMBL20114565 0.91 PTGER4 (0.39) PTGER4CYP1A2CYP3A4MEN1ALDH1A1
SCHEMBL22243008 0.90 CYP1A2 (0.35) PTGER4CYP1A2CYP3A4MEN1ALDH1A1
SCHEMBL20777709 0.89 ABCG2 (0.34) PTGER4SYKLMNAABCG2RXRA
SCHEMBL20150355 0.88 ABCG2 (0.37) PTGER4CYP1A2CYP3A4MEN1ALDH1A1
SCHEMBL20849171 0.88 CYP1A2 (0.34) PTGER4CYP1A2CYP3A4MEN1ALDH1A1
SCHEMBL22243007 0.88 CYP1A2 (0.34) PTGER4CYP1A2CYP3A4MEN1ALDH1A1
SCHEMBL20114548 0.88 PTGER4 (0.41) PTGER4CYP1A2CYP3A4MEN1ALDH1A1
SCHEMBL20150357 0.87 PTGER4 (0.33) PTGER4SYKMAT2AGRM5RXRA
SCHEMBL19912518 0.87 CYP1A2 (0.34) PTGER4CYP1A2CYP3A4MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 PTGER4 1809/4885SYK 338/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.